Nov 21, 2017
Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare Conference
Nov 20, 2017
Neurocrine Biosciences Appoints Matt Abernethy as Chief Financial Officer
Nov 08, 2017
Neurocrine Biosciences to Present at the Jefferies 2017 London Healthcare Conference
Nov 01, 2017
AbbVie Announces Positive Phase 3 Extension Study Data for Investigational Oral Treatment Elagolix for Management of Endometriosis with Associated Pain
Oct 31, 2017
Neurocrine Biosciences to Present at the Credit Suisse 26th Annual Healthcare Conference
Oct 24, 2017
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2017 Results
Sep 06, 2017
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Sep 06, 2017
Neurocrine Biosciences to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
Aug 30, 2017
Neurocrine Biosciences to Present at the Baird 2017 Global Healthcare Conference
Aug 03, 2017
Neurocrine Biosciences Reports Second Quarter 2017 Results
Jul 28, 2017
Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2017 Results
Jul 21, 2017
Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer
Jun 09, 2017
Neurocrine Biosciences to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
Jun 01, 2017
Neurocrine Biosciences to Present at the Jefferies 2017 Global Healthcare Conference